This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 2011-2013.
Company Filing History:
Years Active: 2011-2013
Title: Yumi Hotta: Innovator in Monoclonal Antibody Research
Introduction
Yumi Hotta is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents to her name, her work has the potential to impact medical treatments significantly.
Latest Patents
One of her latest patents is focused on an anti-platelet membrane glycoprotein VI monoclonal antibody. This invention provides an antibody that specifically binds to human platelet membrane glycoprotein VI (GPVI). The antibody is designed to have low activation function for platelets and to induce thrombocytopenia in vivo. Additionally, it partially depletes GPVI on the platelet membrane by contacting with a platelet. This innovative approach could lead to advancements in therapies for various blood-related conditions.
Career Highlights
Yumi Hotta is currently associated with Mochida Pharmaceutical Co., Ltd., where she continues her research and development efforts. Her work is characterized by a commitment to improving healthcare through innovative solutions.
Collaborations
Yumi collaborates with notable colleagues, including Hiroshi Takayama and Kamon Shirakawa. Their combined expertise enhances the research environment and fosters innovation within their projects.
Conclusion
Yumi Hotta's contributions to monoclonal antibody research exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a key figure in the biotechnology field.